Blackstone Announces Additional Investment in AIR Control Concepts
Blackstone to Acquire Madison Dearborn’s Remaining Stake to Become Sole Institutional Investor Supporting AIR’s Next Phase of Growth NORFOLK, Va.–(BUSINESS... Read more.
Quantum to Participate at the Needham Growth Conference on January 15
CENTENNIAL, Colo.–(BUSINESS WIRE)–Quantum Corporation (Nasdaq: QMCO) (“Quantum” or the “Company”), today announced that Hugues... Read more.
BXP and Starr Announce Lease Signing at BXP’s 343 Madison Avenue in Midtown Manhattan
Approximately 275,000 SF Lease Anchors Future Premier Workplace Tower BOSTON–(BUSINESS WIRE)–BXP (NYSE: BXP), the largest publicly traded developer,... Read more.
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution... Read more.
Extreme Networks Names Ron Pasek to Board of Directors
Strengthens Strategic Leadership to Fuel Long-Term Shareholder Value MORRISVILLE, N.C.–(BUSINESS WIRE)–Extreme Networks, Inc. (Nasdaq: EXTR) a leader... Read more.
Zeitro Introduces Scenario AI for Mortgage Origination
SAN FRANCISCO–(BUSINESS WIRE)–Zeitro, a mortgage technology company, today announced the availability of Scenario AI, an agentic AI designed to help... Read more.
B2C Ecommerce Global Forecast Report 2025: Market Projected to Grow by 7.3% to Reach $7.25 Trillion – Forecast to 2029 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “B2C Ecommerce Global Market Size & Forecast by Value and Volume Across 80+ KPIs – Databook Q4 2025 Update”... Read more.
Merck Initiates Phase 3 KANDLELIT-007 Trial Evaluating Calderasib (MK-1084), an Investigational Oral KRAS G12C Inhibitor, in Combination With KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) in Certain Patients With Advanced NSCLC
Third Phase 3 trial in Merck’s KANDLELIT clinical development program, which is investigating calderasib in KRAS G12C-mutant cancers across multiple tumor types... Read more.
JBT Marel Corporation to Host 2026 Investor Day
CHICAGO–(BUSINESS WIRE)–JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM), a leading global technology solutions provider to high-value segments... Read more.
Atmus Filtration Technologies Completes Acquisition of Koch Filter Corporation
NASHVILLE, Tenn.–(BUSINESS WIRE)–Atmus Filtration Technologies Inc. (“Atmus”; NYSE: ATMU), a global leader in filtration and media solutions, today... Read more.